Table 1.
Baseline Characteristics of Patients with Ulcerative Colitis
| Active (n= 7) | Inactive (n=6) | P-value | |
|---|---|---|---|
|
| |||
| Age (years +/− S.D.) | 50.0 +/− 20.4 | 40.2 +/− 13.0 | NS |
|
| |||
| % Male | 43% | 66% | NS |
|
| |||
| TNFα Antagonists Use, % | 29% | 33% | NS |
|
| |||
| Steroid Use, % | 29% | 0% | NS |
|
| |||
| Immunosuppressive Use, % | 14% | 50% | NS |
|
| |||
| Mayo Clinic Score (mean +/− S.D.) | 6.3 +/− 2.1 | 0.3 +/− 0.5 | 0.003 |
|
| |||
| Mayo Clinic Endoscopy Score (mean +/− S.D.) | 2.1 +/− 0.9 | 0.2 +/− 0.9 | < 0.001 |
|
| |||
| Extent of Colitis | |||
| Left-Sided | 57% | 0% | -- |
| Pan-Colitis | 43% | 0% | -- |
S.D. indicates standard deviation.